Related Experiment Video
Updated: Aug 7, 2025

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
Published on: June 20, 2025
SiO2@Au nanoshell-assisted laser desorption/ionization mass spectrometry for coronary heart disease diagnosis
Yanyan Li1, Hua Zhang1, Jingjing Jiang2
1National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan, 610065, China. yunbing.wang@scu.edu.cn.
Insights
This study developed a novel nanomaterial for analyzing coronary heart disease (CHD) metabolism using mass spectrometry. The method shows promise for distinguishing CHD patients from healthy individuals.
Area of Science:
- Biochemistry
- Materials Science
- Medical Diagnostics
Background:
- Cardiovascular diseases, particularly coronary heart disease (CHD), are a leading cause of mortality worldwide.
- CHD is recognized as a metabolic disorder, yet its metabolic pathways remain under-researched.
- Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) offers potential for metabolic profiling but requires optimized sample handling.
Purpose of the Study:
- To develop and optimize a nanomaterial-based approach for high-quality metabolic fingerprinting of CHD.
- To investigate the utility of SiO2@Au nanoshells combined with plasma for CHD metabolic analysis.
- To determine the diagnostic accuracy of this novel method for identifying CHD.
Main Methods:
- Fabrication and optimization of SiO2@Au nanoshells for enhanced laser desorption/ionization.
- Application of the optimized nanoshells with minute plasma samples for metabolic fingerprinting.
- Utilizing MALDI-MS for analyzing metabolic profiles of coronary heart disease patients and controls.
- Validation of the method's performance in distinguishing CHD cases from controls.
Main Results:
- Successful combination of SiO2@Au nanoshells with plasma for metabolic profiling of CHD.
- Optimization of SiO2@Au shell thickness to improve the MALDI-MS signal.
- Achieved 84% sensitivity and 85% specificity in distinguishing CHD patients from controls in a validation cohort.
Conclusions:
- The developed SiO2@Au nanoshell-based MALDI-MS method provides a sensitive and specific approach for CHD metabolic fingerprinting.
- This technique offers a promising tool for the non-invasive diagnosis and metabolic study of coronary heart disease.
- Further research can explore the clinical application of this nanomaterial-based diagnostic strategy.
Abstract:
Cardiovascular diseases have threatened human health, amongst which coronary heart disease (CHD) is the third most common cause of death. CHD is considered to be a metabolic disease; however, there is little research on the CHD metabolism. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) has enabled the development of a suitable nanomaterial that can be used to obtain considerable high-quality metabolic information without complex pretreatment of biological fluid samples. This study combines SiO2@Au nanoshells with minute plasma to obtain metabolic fingerprints of CHD. The thickness of the SiO2@Au shell was also optimized to maximize the laser desorption/ionization effect. The results demonstrated 84% sensitivity at 85% specificity for distinguishing CHD patients from controls in the validation cohort.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Matrix-Assisted Laser Desorption Ionization (MALDI)
The analyte of interest, a biomolecule or a mixture of biomolecules, is mixed with a suitable matrix material. The...
Coronary Artery Disease I: Introduction

